Daniel Brennan
Stock Analyst at TD Cowen
(4.89)
# 287
Out of 4,646 analysts
692
Total ratings
57.5%
Success rate
21.6%
Average return
Main Sectors:
Stocks Rated by Daniel Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SERA Sera Prognostics | Maintained: Buy | n/a | $1.94 | - | 16 | Aug 12, 2026 | |
| QTRX Quanterix | Rated: Hold | $4 → $3 | $3.07 | -2.28% | 18 | Aug 11, 2026 | |
| RVTY Revvity | Rated: Buy | $130 | $117.80 | +10.36% | 26 | Aug 7, 2026 | |
| WAT Waters | Upgraded: Buy | $408 → $475 | $418.52 | +13.50% | 29 | Aug 7, 2026 | |
| NTRA Natera | Rated: Buy | $325 → $340 | $312.18 | +8.91% | 27 | Aug 7, 2026 | |
| PACB Pacific Biosciences of California | Maintained: Buy | $3 | $1.15 | +162.01% | 26 | Aug 6, 2026 | |
| BDSX Biodesix | Reiterated: Buy | $30 | $24.98 | +20.10% | 10 | Aug 6, 2026 | |
| GRAL GRAIL | Maintained: Buy | $88 | $69.22 | +27.13% | 6 | Aug 6, 2026 | |
| XGN Exagen | Reiterated: Buy | $8 → $10 | $6.58 | +51.98% | 16 | Aug 4, 2026 | |
| SOPH SOPHiA GENETICS | Maintained: Buy | n/a | $7.57 | - | 15 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $192 → $210 | $192.07 | +9.34% | 45 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $200 → $210 | $163.41 | +28.51% | 20 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $28 | $25.12 | +11.46% | 17 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $15 | $13.88 | +8.07% | 26 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $16.49 | +15.26% | 23 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $675 | $602.26 | +12.08% | 40 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $240 → $236 | $205.30 | +14.95% | 33 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $43 → $60 | $58.46 | +2.63% | 26 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $40 → $44 | $43.71 | +0.66% | 26 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.5 → $1 | $0.479899 | +108.38% | 12 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $18 | $14.26 | +26.27% | 16 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $47 | $59.10 | -20.47% | 33 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 → $85 | $81.98 | +3.68% | 20 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 → $71 | $54.65 | +29.92% | 20 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $31 → $30 | $22.87 | +31.18% | 9 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $34 | $34.88 | -2.52% | 2 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $157 → $155 | $148.88 | +4.11% | 40 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.88905 | - | 12 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.11 | - | 12 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 | $3.24 | +116.05% | 21 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $183 | $184.25 | n/a | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.5 | $0.79 | n/a | 11 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $525 | $120.43 | n/a | 1 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $47.48 | n/a | 1 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 → $62 | $5.82 | n/a | 3 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $125.39 | n/a | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $390 → $465 | $285.27 | n/a | 7 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $880 → $1,139 | $1,427.69 | n/a | 12 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $224 → $275 | $243.52 | n/a | 4 | Apr 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $174 → $232 | $165.85 | n/a | 8 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $44.37 | n/a | 1 | Nov 26, 2013 |
Sera Prognostics
Aug 12, 2026
Maintained: Buy
Price Target: n/a
Current: $1.94
Upside: -
Quanterix
Aug 11, 2026
Rated: Hold
Price Target: $4 → $3
Current: $3.07
Upside: -2.28%
Revvity
Aug 7, 2026
Rated: Buy
Price Target: $130
Current: $117.80
Upside: +10.36%
Waters
Aug 7, 2026
Upgraded: Buy
Price Target: $408 → $475
Current: $418.52
Upside: +13.50%
Natera
Aug 7, 2026
Rated: Buy
Price Target: $325 → $340
Current: $312.18
Upside: +8.91%
Pacific Biosciences of California
Aug 6, 2026
Maintained: Buy
Price Target: $3
Current: $1.15
Upside: +162.01%
Biodesix
Aug 6, 2026
Reiterated: Buy
Price Target: $30
Current: $24.98
Upside: +20.10%
GRAIL
Aug 6, 2026
Maintained: Buy
Price Target: $88
Current: $69.22
Upside: +27.13%
Exagen
Aug 4, 2026
Reiterated: Buy
Price Target: $8 → $10
Current: $6.58
Upside: +51.98%
SOPHiA GENETICS
Aug 4, 2026
Maintained: Buy
Price Target: n/a
Current: $7.57
Upside: -
Jul 31, 2026
Rated: Hold
Price Target: $192 → $210
Current: $192.07
Upside: +9.34%
Jul 31, 2026
Rated: Buy
Price Target: $200 → $210
Current: $163.41
Upside: +28.51%
Jul 30, 2026
Rated: Buy
Price Target: $25 → $28
Current: $25.12
Upside: +11.46%
Jul 29, 2026
Maintained: Hold
Price Target: $11 → $15
Current: $13.88
Upside: +8.07%
Jul 28, 2026
Maintained: Buy
Price Target: $19
Current: $16.49
Upside: +15.26%
Jul 23, 2026
Maintained: Buy
Price Target: $675
Current: $602.26
Upside: +12.08%
Jul 22, 2026
Reiterated: Buy
Price Target: $240 → $236
Current: $205.30
Upside: +14.95%
Jul 15, 2026
Maintained: Hold
Price Target: $43 → $60
Current: $58.46
Upside: +2.63%
Jul 15, 2026
Maintained: Hold
Price Target: $40 → $44
Current: $43.71
Upside: +0.66%
Jul 15, 2026
Maintained: Buy
Price Target: $1.5 → $1
Current: $0.479899
Upside: +108.38%
Jul 15, 2026
Rated: Buy
Price Target: $10 → $18
Current: $14.26
Upside: +26.27%
Jul 15, 2026
Maintained: Hold
Price Target: $25 → $47
Current: $59.10
Upside: -20.47%
Jul 15, 2026
Maintained: Buy
Price Target: $55 → $85
Current: $81.98
Upside: +3.68%
Jul 15, 2026
Maintained: Buy
Price Target: $68 → $71
Current: $54.65
Upside: +29.92%
Jul 15, 2026
Rated: Buy
Price Target: $31 → $30
Current: $22.87
Upside: +31.18%
Jul 15, 2026
Maintained: Buy
Price Target: $30 → $34
Current: $34.88
Upside: -2.52%
May 27, 2026
Reiterated: Buy
Price Target: $157 → $155
Current: $148.88
Upside: +4.11%
Apr 28, 2026
Maintained: Buy
Price Target: n/a
Current: $0.88905
Upside: -
Feb 26, 2026
Maintained: Buy
Price Target: n/a
Current: $2.11
Upside: -
Feb 23, 2026
Maintained: Hold
Price Target: $7
Current: $3.24
Upside: +116.05%
Jul 14, 2025
Maintained: Hold
Price Target: $183
Current: $184.25
Upside: n/a
May 6, 2025
Maintained: Buy
Price Target: $2.5
Current: $0.79
Upside: n/a
Apr 27, 2023
Maintained: Buy
Price Target: $525
Current: $120.43
Upside: n/a
Apr 26, 2023
Maintained: Buy
Price Target: $45
Current: $47.48
Upside: n/a
Oct 15, 2021
Maintained: Buy
Price Target: $68 → $62
Current: $5.82
Upside: n/a
Oct 14, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $125.39
Upside: n/a
Aug 17, 2021
Maintained: Buy
Price Target: $390 → $465
Current: $285.27
Upside: n/a
May 7, 2021
Maintained: Sell
Price Target: $880 → $1,139
Current: $1,427.69
Upside: n/a
Apr 23, 2021
Maintained: Buy
Price Target: $224 → $275
Current: $243.52
Upside: n/a
Mar 1, 2021
Upgraded: Buy
Price Target: $174 → $232
Current: $165.85
Upside: n/a
Nov 26, 2013
Initiated Coverage: Buy
Price Target: $16
Current: $44.37
Upside: n/a